Bismuth Subsalicylate Oral Suspension from Canada
A liquid mixture containing bismuth subsalicylate as the active ingredient, combined with inorganic suspending agents, used for treating upset stomach, diarrhea, and heartburn. It falls under HTS 3824.99.31.00 as a mixture of two or more inorganic compounds of bismuth not elsewhere specified, specifically formulated for pharmaceutical use.
Duty Rate — Canada → United States
16.5%
Rate breakdown
9903.03.0110%Except for products described in headings 9903.03.02–9903.03.11, articles the product of any country, as provided for in subdivision (aa) of U.S. note 2 to this subchapter
Import Tips
• Verify exact bismuth compound composition to confirm classification under 3824.99.31.00; pharmaceutical mixtures may require FDA registration and drug import alerts
• Include certificates of analysis showing inorganic bismuth content and ensure labeling complies with US pharmacopeia standards to avoid CBP reclassification